Bacterial cellulose (BC) is a nanofibrillar exopolysaccharide synthesized by certain Gramnegative,
obligate aerobic, acetic acid bacteria, the Komagataeibacter genus being the most
important due to the high cellulose yield obtained. The unique properties of this biopolymer
have supported a wide range of potential applications, in human and veterinary medicine,
odontology, pharmaceutical industry, acoustic and filter membranes, biotechnological devices
and in the food and paper industry. The large-scale production of BC, through advanced
biotechnology has eluded many researches. Historical attempts but on low volume and highvalue
(mostly for biomedical applications) production can be traced back to the 90s.
This presentation will overview the potential uses of BC in several applications. Also, it will
present Satisfibre, S.A., a spin-off from the University of Minho (Portugal). Through R&D
activities, networking & partnering with industry, Satisfibre aims to bring new and improved
solutions, based on the use BC, to the food sector, biomedical, composites, pulp & paper and
textile industries. Examples of successful product development and industry networking will be
shown. Finally, an overview on the main efforts towards the production of BC at large scale
and potential markets will also be presented.info:eu-repo/semantics/publishedVersio
